Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research and development unit to manufacture high-end biosimilars and biopharmaceuticals.
The company... Full Story
Shanghai Fosun Pharmaceutical (Group) Co. Ltd, the Hong Kong-listed company controlled by billionaire Guo Guangchang, said it had submitted a... Full Story
Browse All News by Date
Alembic Pharmaceuticals Ltd (APL) has formed a 60:40 joint venture (JV) with the Hyderabad-based Orbicular Pharmaceutical Technologies Pvt Ltd to... Full Story
More Top Stories
For all enquiries please contact
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher) Copyright © 2016-2018